Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques (Q45400137)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

author name string

Matthew B Elliott

1

1 reference

Europe PubMed Central

14 December 2017

Tong Chen

2

1 reference

Europe PubMed Central

14 December 2017

Nicole B Terio

3

1 reference

Europe PubMed Central

14 December 2017

Siew-Yen Chong

4

1 reference

Europe PubMed Central

14 December 2017

Rashed Abdullah

5

1 reference

Europe PubMed Central

14 December 2017

Amara Luckay

6

1 reference

Europe PubMed Central

14 December 2017

Michael A Egan

7

1 reference

Europe PubMed Central

14 December 2017

Lee Anne Boutilier

8

1 reference

Europe PubMed Central

14 December 2017

Krista Melville

9

1 reference

Europe PubMed Central

14 December 2017

Robert A Lerch

10

1 reference

Europe PubMed Central

14 December 2017

Deborah Long

11

1 reference

Europe PubMed Central

14 December 2017

John H Eldridge

12

1 reference

Europe PubMed Central

14 December 2017

Christopher L Parks

13

1 reference

Europe PubMed Central

14 December 2017

Stephen A Udem

14

1 reference

Europe PubMed Central

14 December 2017

Gerald E Hancock

15

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

21 August 2007

1 reference

Europe PubMed Central

14 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

41

1 reference

Europe PubMed Central

14 December 2017

7132-7144

1 reference

Europe PubMed Central

14 December 2017

Immunopathology of RSV infection: prospects for developing vaccines without this complication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A review of vaccine research and development: human acute respiratory infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Prevention and treatment of respiratory syncytial virus infection in infants: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Immune-mediated disease pathogenesis in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus: reverse genetics and vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Carriers for the delivery of a vaccine against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus immunobiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic and genetic variation in human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Two distinct subtypes of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Local CD11c+ MHC class II- precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

A novel viral system for generating antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

Respiratory syncytial virus mRNA coding assignments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.07.065

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45400137&oldid=2076602263"